Physician profile
John Battin
NPI 1003866641
$4,653.97
in general payments reported to CMS, 2019-2025
34 companies · $1,120 in 2025
The $1,120 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $566 · 2020: $262 · 2021: $253 · 2022: $499 · 2023: $1,042 · 2024: $912 · 2025: $1,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,074.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $736.79 | 2019-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $636.84 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $571.58 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $424.81 | 2023-2025 | Provenge |
| Myriad Genetic Laboratories, INC. | $193.14 | 2020-2024 | Prolaris |
| Abbvie INC. | $183.92 | 2019-2025 | |
| Tolmar, INC. | $179.69 | 2023-2025 | Jatenzo, Eligard |
| Urogen Pharma, INC. | $164.26 | 2022-2025 | Jelmyto |
| Janssen Biotech, INC. | $133.83 | 2023-2025 | Erleada |
| Axonics, INC. | $120.79 | 2021-2024 | Axonics |
| Antares Pharma, INC. | $115.00 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Novartis Pharmaceuticals Corporation | $106.23 | 2023-2025 | |
| Cumberland Pharmaceuticals, INC. | $103.02 | 2019-2023 | Caldolor |
| Myovant Sciences INC. | $97.41 | 2021-2022 | |
| Coloplast Corp | $97.05 | 2022-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $92.90 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $88.40 | 2020-2025 | Keytruda, Welireg, Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $86.03 | 2019-2024 | |
| Boston Scientific Corporation | $85.71 | 2019-2024 | Ams 700 |
| Procept Biorobotics Corporation | $75.45 | 2019-2025 | Aquabeam Robotic System |
| Tolmar Pharmaceuticals, INC. | $74.43 | 2020-2022 | |
| Foundation Medicine, INC. | $35.68 | 2022-2023 | |
| Davol INC. | $33.27 | 2024 | Arista Ah Flexitip |
| Ferring Pharmaceuticals INC. | $28.86 | 2019 | |
| Biotissue Holdings INC. | $25.28 | 2024 | |
| Agiliti Surgical, INC. | $24.30 | 2023 | Cryocare Cs, Sonablate, Trinity |
| Immunitybio, INC. | $23.84 | 2025 | |
| Novo Nordisk INC | $22.95 | 2024 | Rivfloza |
| Teleflex LLC | $19.71 | 2025 | Barrigel |
| Medtronic USA, INC. | $17.80 | 2019 | |
| Provepharm INC. | $14.29 | 2025 | Bludigo |
| Genzyme Corporation | $14.04 | 2020 | |
| Neotract INC. | $13.98 | 2019 | |
| Halozyme INC | $12.69 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Battin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.